For single-use pens, discard after use or if the out-of-refrigerator time limit is exceeded before use
This guide covers everything you need to know about adjusting your GLP-1 dose schedule if you, for any reason, miss your scheduled shot
Weight Reduction Mechanisms and Outcomes The weight-reducing effects of GLP-1 RAs are primarily attributed to reduced food intake rather than increased energy expenditure
For those new to GLP-1 treatments, starting with an easy-to-use format offering sustained effectiveness, like Orforglipron, is a preferable option
TrimRxs compounded tirzepatide provides the same active ingredient as Mounjaro at lower cost without insurance requirements
Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868)